Navigation Links
In Final Hour Prior to Litigation, Angel MedFlight's Air Ambulance Team Overturns Decision by Major Insurance Company
Date:8/31/2009

SCOTTSDALE, Ariz., Aug. 31 /PRNewswire/ -- Last year, Sally (a patient suffering from end stage liver failure) was in need of life flight transportation to be evaluated for a liver transplant. Her doctors told her she needed to receive the evaluation in order to get on the transplant list. Travel by ground ambulance or commercial flight were not an option due to her condition. Her health insurance company told her they would not cover the air ambulance medical transport. But last week, after four appeals and countless hours of work by Angel MedFlight's patient advocates, that decision was reversed. The insurance company will now pay the full amount of the air ambulance service provided by Angel MedFlight.

"When health insurance companies deny authorization every air ambulance company runs for the hills," said Jeremy Freer, Angel MedFlight CEO. "If they cannot get paid in advance, either from insurance or from the patient's family, they will not conduct the life flight. That's one of the big differences that sets Angel MedFlight apart from other air ambulance services. We will provide the care needed by the patient when no one else will."

Like many health insurance companies, Sally's insurer initially refused to approve the air ambulance service on the grounds that it was "not medically necessary." At that point, she was faced with two options: (1) giving up the chance of a transplant, or (2) taking the time to try and raise thousands of dollars for the life flight. "Sally may have had options but, sadly, she did not have extra time," Freer said. "That is when Angel MedFlight stepped in, reviewed her insurance policy and conducted the flight."

After conducting the life flight, Angel MedFlight's legal team, led by attorney Kelly LoCascio, Esq., went to bat for Sally. The claim was governed by the Employee Retirement Income Security Act of 1974 (ERISA), a federal law governing most health insurance policies that LoCascio says most patients and even many lawyers do not understand.

"Unfortunately, some health insurance companies frequently deny coverage for health benefits when they should be paid," LoCascio said. "They deny claims knowing patients will not understand the intricacies of ERISA law and often do not have the resources to hire a lawyer. Sometimes the patient is too involved with their health or just tired of the fight, and subsequently will miss crucial appeal deadlines. We take on the battle so our patients don't have to. In Sally's case, the system worked; Angel MedFlight performed the service, the insurer denied benefits, and after much exhaustive effort Angel MedFlight ensured that the insurance company carried out their obligations."

About Angel MedFlight Worldwide Air Ambulance Services:

Founded in 2006, Angel MedFlight is a full-service provider for medical ground and air ambulance transport. Part of Angel MedFlight's mission is to fulfill the urgent need for integrity and excellence in the air ambulance industry. Only the best aircraft, equipment and personnel are used. Angel MedFlight delivers on their promises, and goes to any lengths to make patient transport as smooth, comfortable and worry-free as possible.

    Contact Information:
    Mark Yost
    Business Development Manager
    myost(at)angelmedflight(dot)com
    877-264-3570
    www.angelmedflight.com


'/>"/>
SOURCE Angel MedFlight Worldwide Air Ambulance Services
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nielsen Announces Final Entry Deadline Extension of September 10th for the First-Ever CLIO Healthcare Awards
2. Dont Miss Twinlabs(R) 2009 Mobile Beach Bash Grand Finale Celebration Labor Day Weekend
3. HBA Global Announces Finalists for the 2009 International Package Design Awards (IPDA)
4. Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets
5. Purple Communications Invites Greater San Ramon Community to Celebrate Ms. Ella Mae Lentz, Finalist in Dream Bigger Initiative
6. Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
7. Covance and Merck & Co., Inc. Finalize Strategic Agreement
8. Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
9. Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets
10. AlloSource Chosen as Healthcare Finalist in 2009 Top Companies
11. Detroit Physician Among 10 Finalists for J.H. Kanter Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 2017 , ... The National Business Research Institute (NBRI) is ... Emergency Medical Technicians and welcomes this organization to the NBRI Circle of ... Ph.D. , CEO & Organizational Psychologist at NBRI. “This award is a result ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced ... farmers produce more and better food, with fewer resources. It highlights the business’ ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, a ... first in a new class of photodynamic cosmetics (PDC). , Allumera® is the ... reduce outward signs of aging, and minimize the appearance of pores – all ...
(Date:4/25/2017)... , ... April 25, 2017 , ... A stressful work ... work can also decrease overall productivity and performance in the workplace. The goal of ... During the last few weeks of April, Clearview Resolution Services will be shutting down ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: